RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 159, doi. 10.32604/or.2022.03458
- By:
- Publication type:
- Article
Works matching IS 09650407 AND DT 2021 AND VI 29 AND IP 3
Results: 6
1
2
Long noncoding RNA CCDC183-AS1 depletion represses breast cancer cell proliferation, colony formation, and motility by sponging microRNA-3918.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 189, doi. 10.32604/or.2022.03573
- By:
- Publication type:
- Article
3
Computational docking and in vitro analysis identifies novel arylidene analogue FPMXY-14 against renal cancer cells by attenuating Akt.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 217, doi. 10.32604/or.2022.03570
- By:
- Publication type:
- Article
4
The LncRNA FEZF1-AS1 promotes tumor proliferation in colon cancer by regulating the mitochondrial protein PCK2.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 201, doi. 10.32604/or.2022.03553
- By:
- Publication type:
- Article
5
Long noncoding RNA LINC01124 activates hepatocellular carcinoma cell proliferation, migration, and invasion by absorbing microRNA-1247-5p and overexpressing FOXO3.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 175, doi. 10.32604/or.2022.03550
- By:
- Publication type:
- Article
6
Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cells.
- Published in:
- Oncology Research, 2021, v. 29, n. 3, p. 149, doi. 10.32604/or.2022.03539
- By:
- Publication type:
- Article